The rising popularity in GLP-1 agonists for diabetes has led to a discussion about delivery methods : skin-applied devices versus pills . Usually , GLP-1 treatments were solely available in tablet form, but the development of skin applications offers a different way. Patches might benefit individuals with issues with pills , those seeking to reduce